Variantyx

Since 2014 / Life Sciences

www.variantyx.com/

CEO

Haim Neerman

Entrepreneur/s

Haim Neerman | Noam Shomron | Tomer Jackman

NEWS

Variantyx Closes $7M Financing Round Led by Pitango

Read More >

Board Member

Guy Ezekiel, M.D.


CONTACT
Variantyx

Variantyx was founded in early 2014 by Haim Neerman, Noam Shomron and Tomer Jackman as a joint venture with the Sackler School of Medicine of Tel-Aviv University. 

The Company is pioneering a paradigm shift in genomic diagnostics with its Genomic Intelligence® technology The genomic diagnostic industry is at an inflection point, shifting from traditional technologies to Whole Genome Sequencing (WGS). Yet the barrier to entry for clinical WGS testing is high, preventing the vast majority of hospitals worldwide from conducting these tests in-house. Variantyx’s Genomic Unity™ is the industry’s first comprehensive WGS-based diagnostic test, effectively combining all genomic diagnostic tests into one, providing high diagnostic yield while lowering the cost and turnaround time.

The traditional diagnostic odyssey for an undiagnosed genetic has been reported to cost $27,000* on average and takes years to conclude. In comparison, Genomic Unity™ costs less than $5,000 and takes two weeks. The company’s services are used by a global network of world-leading hospitals and diagnostic labs and are reimbursed by the major US payors.

The company’s service is integrated with a global network of world-leading sequencing partners, including Boston Children’s, Vanderbilt, Colorado Children’s, UC Irvine, Quest Diagnostics, the world’s largest laboratory and Clalit Health Services the world’s second largest HMO and many others. Unity™ is reimbursed by major US payors including Cigna, United and BCBS.